This is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE).
- Investigators
- Christopher Harden, Divya C Patel
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Sarcoidosis , 3 publications
- Lung Diseases, Interstitial , 3 publications
- Lung , 2 publications
- Alveolitis, Extrinsic Allergic , 2 publications
Research activity
Active clinical trials
This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.
- Investigators
- Christopher Harden, Divya C Patel
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
This is a Phase 2, multicenter, multinational, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, pharmacokinetics (PK), quality of life and exploratory pharmacodynamics (PD) of two treatment doses of CC-90001, 200…
- Investigator
- Divya C Patel
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
My publications
Filter publications
28 publications
2023
Genome-wide association study identifies multiple HLA loci for sarcoidosis susceptibility.
Human molecular genetics
PubMed • Publisher's site2023
Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial
JCI Insight
PubMed • Publisher's site2022
A 43-Year-Old Woman With Pleuritic Chest Pain, Shortness of Breath, and Weakness of All Extremities
Chest
Publisher's site2022
Diffuse pulmonary calcification in allergic bronchopulmonary aspergillosis.
Respiratory medicine case reports
PubMed • Publisher's site2022
Lung transplantation for acute exacerbation of interstitial lung disease.
Thorax
PubMed • Publisher's site